Quantum Corp Files 8-K on Shareholder Nominations

TL;DR

Quantum Corp filed an 8-K, looks like shareholder nominations are on the table.

AI Summary

Quantum Corporation filed an 8-K on October 20, 2025, reporting on shareholder nominations pursuant to Exchange Act Rule 14a-11 and other events. The company, incorporated in Delaware with its principal executive offices in San Jose, CA, has its common stock traded on the Nasdaq Global Market under the symbol QMCO.

Why It Matters

This filing indicates potential changes or discussions regarding board composition and corporate governance, which could impact the company's strategic direction.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of corporate events and does not immediately suggest significant financial or operational risks.

Key Numbers

• 001-13449 — SEC File Number (Identifies the company's filing with the SEC.)
• 94-2665054 — EIN (Employer Identification Number for tax purposes.)

Key Players & Entities

• Quantum Corporation (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• San Jose, CA (location) — Principal Executive Offices
• QMCO (stock_symbol) — Trading Symbol for Common Stock
• Nasdaq Global Market (exchange) — Exchange for Common Stock
• October 20, 2025 (date) — Date of Report

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value per share QMCO Nasdaq Global

Filing Documents

• qtm-20251020.htm (8-K) — 26KB
• qtm-20251020_g1.jpg (GRAPHIC) — 12KB
• 0000709283-25-000063.txt ( ) — 158KB
• qtm-20251020.xsd (EX-101.SCH) — 2KB
• qtm-20251020_lab.xml (EX-101.LAB) — 21KB
• qtm-20251020_pre.xml (EX-101.PRE) — 12KB
• qtm-20251020_htm.xml (XML) — 3KB

08 Shareholder Director Nominations

Item 5.08 Shareholder Director Nominations. To the extent applicable, the information in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.08.

01 Other Events

Item 8.01 Other Events. Quantum Corporation (the "Company") has established December 16, 2025 as the date for its 2025 annual meeting of stockholders (the "Annual Meeting"). A stockholder proposal not included in the proxy statement for the Annual Meeting will not be eligible for presentation at the meeting unless the stockholder gives timely notice of the proposal in writing to the Company's Secretary at its principal executive offices and otherwise complies with the provisions of the Company's Amended and Restated Bylaws (the "Bylaws"). To be timely, the Bylaws provide that the Company must have received the stockholder's notice not later than the 45th day nor earlier than the 75th day before the one-year anniversary of the date on which the Company first mailed its proxy materials or a notice of availability of proxy materials (whichever is earlier) for the preceding year's annual meeting of stockholders. However, because the date of the Annual Meeting is delayed by more than 60 days after the one-year anniversary of the 2024 annual meeting, the Company must receive the stockholder's notice not earlier than the close of business on the 120th day before the Annual Meeting and not later than the close of business on the later of (i) the 90th day before the Annual Meeting, and (ii) the tenth day after public announcement of the Annual Meeting date. For the Annual Meeting, stockholders must submit written notice to the Secretary in accordance with the Bylaws no later than the close of business on October 30, 2025. In addition to complying with the October 30, 2025 deadline, stockholder proposals intended to be considered for inclusion in the Company's proxy materials and director nominations for the Annual Meeting must also comply with all applicable Securities and Exchange Commission rules, including Rule 14a-8 and Rule 14a-19, Delaware corporate law, and the Bylaws in order to be eligible for inclusion in the proxy materials for the Annual Meeting. SIGNATURE

View Full Filing

View this 8-K filing on SEC EDGAR